Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Non-cash Items: 2014-2020

Historic Non-cash Items for ImmunityBio (IBRX) over the last 7 years, with Dec 2020 value amounting to $21.9 million.

  • ImmunityBio's Non-cash Items fell 37.37% to $19.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was $19.0 million, marking a year-over-year decrease of 37.37%. This contributed to the annual value of $21.9 million for FY2020, which is 283.92% up from last year.
  • Latest data reveals that ImmunityBio reported Non-cash Items of $21.9 million as of FY2020, which was up 283.92% from $5.7 million recorded in FY2019.
  • In the past 5 years, ImmunityBio's Non-cash Items registered a high of $21.9 million during FY2020, and its lowest value of $563,000 during FY2018.
  • Over the past 3 years, ImmunityBio's median Non-cash Items value was $5.7 million (recorded in 2019), while the average stood at $9.4 million.
  • In the last 5 years, ImmunityBio's Non-cash Items plummeted by 95.28% in 2018 and then skyrocketed by 914.21% in 2019.
  • Over the past 5 years, ImmunityBio's Non-cash Items (Yearly) stood at $19.1 million in 2016, then slumped by 37.59% to $11.9 million in 2017, then slumped by 95.28% to $563,000 in 2018, then surged by 914.21% to $5.7 million in 2019, then skyrocketed by 283.92% to $21.9 million in 2020.